MLH1 and endometrial cancer: The proband was diagnosed with three primary LS-associated tumors (one endometrial cancer at the age of 55 years and two CRCs (at the ages of 54 and 59 years), immunohistochemical analysis was available from the latter, which confirmed the decreased expression of MLH1 and PMS2).